Project description DEENESFRITPL Relieving the pressure involved in sorting things out High-performance liquid chromatography (HPLC), formerly known as high-pressure liquid chromatography, is a commonly used and extremely powerful technique for separating the components of a liquid mixture. Among its many areas of use are pharmaceuticals and foods and beverages development, bioanalytics, clinical medicine and environmental analyses. A sample in a solvent is pumped at high pressure through a column, and the compounds in the sample are separated. The French SME Separative has developed reusable low-pressure HPLC columns that reduce the cost of conventional chromatography by a factor of 10–50. The EU-funded Separative project is helping the team conduct an automation study, a value chain organisation analysis and a marketing mix review. Show the project objective Hide the project objective Objective SEPARATIVE is a novel chemical purification and analysis method based on a ground-breaking multicapillary material and the related manufacturing process, both protected by four patents. This brand-new material allows to offer reusable low-pressure High-Performance Liquid Chromatography (HPLC) columns. It is the first innovation that achieves chromatographic purification and analysis results without the high pressure and high cost of the state-of-the-art chromatography. SEPARATIVE reduces the cost of current chromatography by a factor of 10-50. Within the pharmaceutical chromatography market, four types of columns are. Two of these types – flash and preparative – can directly be reached with our first market entrance product range. The flash columns market size is around €240 million and the preparative €110 million. Of those €350 million, we will reach around €240 million with our first business case and then extend the range and the span of the obtainable market. There is a dynamic growth trend with flash columns growing at 10% annually and preparative at 5%. Being able to use chromatography beyond the experimentation phase would bring several technological advantages to the healthcare industry: Better quality of drugs due to higher purity, lower investments for production plants (savings of 59% for separation), lower manufacturing costs due to better yields (no losses of valuable material in process) and higher security of manufacturing process due to lower volumes of flammable and toxic solvents. This accelerates pharmaceutical innovation and allows citizens to have access to drugs faster.SEPARATIVE SAS is a start-up hosted at IFPEN (IFP Energies Nouvelles, a major development centre for process industries, renowned worldwide and Nobel Prize for Chemistry in 2005). We are a team of 5 experienced and complementary experts and have access to a great network in chemical engineering as the IFPEN site hosts global leaders such as Total, Solvay, Bluestar and Arkema Fields of science social scienceseconomics and businesseconomicsproduction economicsproductivityengineering and technologychemical engineeringseparation technologies Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-1 Funding Scheme SME-1 - SME instrument phase 1 Coordinator SEPARATIVE Net EU contribution € 50 000,00 Address PMI 87 AVENUE DES FRERES PERRET CHEZ AXEL ONE 69190 Saint Fons France See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Auvergne-Rhône-Alpes Rhône-Alpes Rhône Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00